Vaxxinity Inc Sustainability Reports
Vaxxinity, Inc. is a biotechnology company focused on developing a new class of synthetic peptide-based immunotherapeutic vaccines. The company designs product candidates to prevent and treat various infectious and chronic diseases, such as Alzheimer's and Parkinson's.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG00ZWVMKN4
1 reports from 2022 to 2022
Company Profile
Vaxxinity, Inc. is a biotechnology company focused on developing a new class of synthetic peptide-based immunotherapeutic vaccines. The company designs product candidates to prevent and treat various infectious and chronic diseases, such as Alzheimer's and Parkinson's.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years